Ritse Mann MD, PHDHead of Breast Imaging UMC St Radboud, Nijmegen, The Netherlands
Dr. Luis Pina shares insights on TiCEM: The unique titanium filter helps avoid overheating and increases accuracy and sensitivity compared to Mammography, while maintaining specificity.
The future of breast cancer screening with DBT is a highly debated topic. There are various topics to be considered. Prof. Sechopoulos gives an overview of the key parameters for screening programs, with a special emphasis on the role of dose.
Researchers at MUSC are currently comparing 2D to 3D and 1-view 3D in breast screening. Initial results show that with 1-view, they save time and dose, while achieving a higher detection rate compared to 2D. Can we omit 2D acquisition in the future?
The Malmö Breast Screening Trial focuses on DBT screening performance, effectiveness and reduced reading time. Prof. Zackrisson concludes that 1-view tomosynthesis with minimum compression increases cancer detection and can be feasible in screening.
What will be the role of synthetic mammograms in screening in the future? And, what improvements can we expect? Prof. Dr. van Ongeval presents the current study landscape and presents a new study comparing synthetic mammograms to FFDM.
DBT, a promising method for screening, significantly increases the number of images, in turn increasing the workload. Prof.Dr. Heywang-Köbrunner explains how various CAD solutions could help, especially when it comes to replacing a second human reader.
The future of screening with DBT: what are the main parameters to be considered? Get a short synopsis of these parameters: reduction in mortality, personalized screening, detection performance, attendance rate, dose, as well as workflow and reading aspects.
What is needed to provide personalized screening in the future? While DBT may become the methode of choice for screening, there are further factors to be considered. Mireille Broeders highlights the role of breast density and how automated measurements could help.
Dr. Evelyn Wenkel and Dr Paola Clauser show how the interaction of various modalities in breast cancer diagnostics is crucial. Using cases from their clinical routine, they draw conclusions for the role of DBT, MRI and ultrasound.
Dr. Tina Manoharan, Forchheim, Germany
Prof. Dr. Luis Javier Pina Insausti, Pamplona, Spain
Prof. Wei Zhao, PhD, New York, USA
Paul Fisher, M.D., New York, USA
Dr. Wayne Lemish, Melbourne, Australia